15 results found.

Type 2 Diabetes Mellitus Clinical Trial using MK-3102; Placebo to MK-3102; Glipizide; Placebo to glipizide; Insulin

Merck Sharp & Dohme Corp. - Recruiting 30 years or older.
- A Phase III, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of MK-3102 Versus Placebo in Subjects With Type 2 Diabetes Mellitus With Moderate or Severe Chronic Kidney Disease or Kidney Failure on Dialysis Who Have Inadequate Glycemic Control.
MK-3102; Placebo to MK-3102; Glipizide; Placebo to glipizide; Insulin

Anemia, or Kidney Failure, Chronic Clinical Trial using Sotatercept

Celgene Corporation - Recruiting 18 years or older.
- A Phase 2 Multicenter, Randomized, Open-Label , Multiple-Dose Study of Intravenous and Subcutaneous Administration of Sotatercept (ACE-011) in Subjects With End-Stage Kidney Disease on Hemodialysis Switched From Erythropoiesis Stimulating Agents With Staggered Dose Group Escalation in Part 1 Followed by a Parallel Group, Active Controlled Study of Selected Dose(s) and Regimen(s) in Part 2: To Evaluate the Pharmacokinetics, Safety, Tolerability, Efficacy, Dosing Regimen, and Pharmacodynamics of Sotatercept.
Sotatercept

Kidney Failure, Chronic, or Renal Insufficiency, Chronic Clinical Trial using LY2409021

Eli Lilly and Company - Recruiting 18 years to 85 years.
- Pharmacokinetics of LY2409021 Following Administration to Subjects With Varying Degrees of Renal Function.
LY2409021

Heart Failure Clinical Trial using BAY94-8862; Eplerenone; Placebo

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Double-dummy, Multi-center Study to Assess Safety and Efficacy of BAY94-8862 in Japanese Subjects With Emergency Presentation at the Hospital Because of Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone Versus Eplerenone.
BAY94-8862; Eplerenone; Placebo

Kidney Failure, Chronic Clinical Trial using ticagrelor

AstraZeneca - Recruiting 18 years to 80 years.
- A Single Dose, Randomized, Open-Label, Parallel Group Study Comparing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Ticagrelor in Hemodialyisis Patients to Subjects With Normal Renal Function.
ticagrelor

Kidney Disease, Kidney Transplantation, or Kidney Failure, Chroni Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes.

Hyperkalemia, or Chronic Kidney Failure Clinical Trial using Sodium polystyrene sulfonate; Lactose with carob gum

Maisonneuve-Rosemont Hospital - Recruiting 18 years or older.
- Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Ambulatory Pre-dialysis Outpatients : a Randomized Triple-blind Placebo-controlled Trial.
Sodium polystyrene sulfonate; Lactose with carob gum

Heart Failure Clinical Trial using BAY94-8862; Placebo; Inspra (eplerenone)

Bayer - Recruiting 18 years or older.
- A Randomized, Double-blind, Double-dummy, Multi-center Study to Assess Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Emergency Presentation at the Hospital Because of Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone Versus Eplerenone.
BAY94-8862; Placebo; Inspra (eplerenone)

End-stage Renal Disease, or Kidney Failure, Chronic Clinical Trial using HAVG graft implantation

Humacyte, Inc. - Recruiting 18 years to 75 years.
- A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease.
HAVG graft implantation

Chronic Kidney Failure Clinical Trial using Boost High Protein

Texas A&M University - Recruiting 55 years or older.
- Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function.
Boost High Protein

Chronic Renal Failure Clinical Trial using Static incubation; Pulsatile perfusion

Hospices Civils de Lyon - Recruiting 18 years to 80 years.
- Interest of Pulsatile Perfusion Preservation on Outcomes in Kidney Transplantation From Expanded Criteria Donors.
Static incubation; Pulsatile perfusion

Kidney Failure, Chronic, or End Stage Renal Disease, Requiring Di Clinical Trial using NxStage System One

NxStage Medical - Recruiting 18 years or older.
- Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStager System OneT.
NxStage System One

Kidney Failure, Chronic Clinical Trial using Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose.

Consorzio Mario Negri Sud - Recruiting 18 years or older.
- Effects of the Dose of Erythropoiesis Stimulating Agents on Cardiac-cerebrovascular Outcomes Quality of Life and Costs in Hemodialysis Patients. The Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) Trial.
Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose.

Chronic Kidney Failure Clinical Trial using Kibow Biotics

Kibow Biotech Inc. - Recruiting 18 years to 75 years.
- Observational Clinical Trials of Kibow Biotics (a Patented and Proprietary Probiotic Dietary Supplement) in Dialysis Patients, in Conjunction With Standardized Care of Treatment.
Kibow Biotics